I read post #3 twice before replying, because I had assumed the opposite.
Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete certificate.
I read post #3 twice before replying, because I had assumed the opposite.
Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete certificate.
Coming back to post #13, because the follow-up matters more than the original answer.
Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.
The correction was fair and I had been repeating something I had not checked carefully enough.
Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.
Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be stated separately from the purity.
Picking up post #58: that is the part I would want checked first.
Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural isomer with the same mass but a different sequence. No chromatographic purity method detects this without a reference standard.
Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be stated separately from the purity.
Read the full topic (128 posts)
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Particulates in a reconstituted solution: identifying the likely source
Posting this under the heading it deserves: Particulates in a reconstituted solution: identifying the likely source Everything below is what sits behind that. Posting the method first, because I know what the…
|
+15 | 19 | 13k | 9mo |
|
Impurity thresholds: where the common numbers come from
Impurity thresholds: where the common numbers come from — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a certificate in…
|
+11 | 15 | 825 | 2d |
|
Racemisation and why it is invisible to a mass measurement — what changed since
Racemisation and why it is invisible to a mass measurement — what changed since Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I…
|
+11 | 15 | 42k | 16d |
|
Second pass at: Where impurities in solid-phase peptide synthesis come from
Posting this under the heading it deserves: Second pass at: Where impurities in solid-phase peptide synthesis come from Everything below is what sits behind that. A documentation question rather than an…
|
+47 | 51 | 3.3k | 5mo |
|
Endotoxin and why it is a separate question from purity
Endotoxin and why it is a separate question from purity Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand what this number means before I repeat it…
|
2 | 22k | 4mo |
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Second pass at: Where impurities in solid-phase peptide synthesis come from
Posting this under the heading it deserves: Second pass at: Where impurities in solid-phase peptide synthesis come from Everything below is what sits behind that. A documentation question rather than an…
|
+47 | 51 | 3.3k | 5mo |
|
Why I ask for the gradient before I discuss the number
The question in the title: Why I ask for the gradient before I discuss the number I will give what I have already checked below so nobody repeats it. I would like to understand what this number means before I…
|
+35 | 39 | 4.9k | 20mo |
|
Deletion sequences: expected mass shifts by residue
Deletion sequences: expected mass shifts by residue — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I would like it checked. semaglutide has a…
|
2 | 59 | 3mo | |
|
Column chemistry choices for a 40-residue peptide
Column chemistry choices for a 40-residue peptide — setting out what I have, and where I think it stops being reliable. Posting the method first, because I know what the first three replies will otherwise be.…
|
+39 | 43 | 1.1k | 10mo |
|
Second pass at: What a 2 ppm match establishes, and what it does not
Second pass at: What a 2 ppm match establishes, and what it does not — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I would like it checked.…
|
+44 | 49 | 8.1k | 1d |